These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 30584686)
1. Tumor multifocality with vagus nerve involvement as a phenotypic marker of SDHD mutation in patients with head and neck paragangliomas: A Amodru V; Romanet P; Scemama U; Montava M; Fakhry N; Sebag F; Castinetti F; Lavieille JP; Loundou A; Varoquaux A; Barlier A; Pacak K; Taïeb D Head Neck; 2019 Jun; 41(6):1565-1571. PubMed ID: 30584686 [TBL] [Abstract][Full Text] [Related]
2. Functional imaging of SDHx-related head and neck paragangliomas: comparison of 18F-fluorodihydroxyphenylalanine, 18F-fluorodopamine, 18F-fluoro-2-deoxy-D-glucose PET, 123I-metaiodobenzylguanidine scintigraphy, and 111In-pentetreotide scintigraphy. King KS; Chen CC; Alexopoulos DK; Whatley MA; Reynolds JC; Patronas N; Ling A; Adams KT; Xekouki P; Lando H; Stratakis CA; Pacak K J Clin Endocrinol Metab; 2011 Sep; 96(9):2779-85. PubMed ID: 21752889 [TBL] [Abstract][Full Text] [Related]
3. 18F-FDG PET/CT as a predictor of hereditary head and neck paragangliomas. Blanchet EM; Gabriel S; Martucci V; Fakhry N; Chen CC; Deveze A; Millo C; Barlier A; Pertuit M; Loundou A; Pacak K; Taïeb D Eur J Clin Invest; 2014; 44(3):325-332. PubMed ID: 24422786 [TBL] [Abstract][Full Text] [Related]
4. Exploring the link between tumour metabolism and succinate dehydrogenase deficiency: A Reichert T; Fakhry N; Lavieille JP; Amodru V; Sebag F; Romanet P; Loundou A; Castinetti F; Pacak K; Montava M; Taïeb D Clin Endocrinol (Oxf); 2019 Dec; 91(6):879-884. PubMed ID: 31479526 [TBL] [Abstract][Full Text] [Related]
11. Trimodal (18)F-DOPA PET/CT/MR fusion imaging for optimal restaging of head and neck paragangliomas in a SDHD mutation carrier. Treglia G; Ruberto T; Giovanella L Endocrine; 2016 May; 52(2):397-8. PubMed ID: 25860886 [No Abstract] [Full Text] [Related]
12. Reduced Risk of Corporal Tumors in Patients With Head and Neck Paragangliomas With p.Pro81Leu Mutations. Miller KM; Sbeih F; Contrera K; Reddy CA; Marquard J; Eng C; Lorenz RR Otolaryngol Head Neck Surg; 2023 Sep; 169(3):570-576. PubMed ID: 36939592 [TBL] [Abstract][Full Text] [Related]
13. Report of a vagal paraganglioma at the cervicothoracic junction. Yun J; Kapustin D; Omorogbe A; Rubin SJ; Nicastri DG; De Leacy RA; Khorsandi A; Urken ML Head Neck; 2023 Oct; 45(10):E36-E43. PubMed ID: 37548094 [TBL] [Abstract][Full Text] [Related]
14. Identification of three new variants of SDHx genes in a cohort of Portuguese patients with extra-adrenal paragangliomas. Domingues R; Montalvão P; Magalhães M; Santos R; Duarte L; Bugalho MJ J Endocrinol Invest; 2012 Dec; 35(11):975-80. PubMed ID: 22293219 [TBL] [Abstract][Full Text] [Related]
16. Vagal body tumor: paraganglioma of the head and neck. Persson AV; Frusha JD; Dial PF; Jewell ER CA Cancer J Clin; 1985; 35(4):232-7. PubMed ID: 2990640 [TBL] [Abstract][Full Text] [Related]
17. Genetic analysis of mitochondrial complex II subunits SDHD, SDHB and SDHC in paraganglioma and phaeochromocytoma susceptibility. Astuti D; Hart-Holden N; Latif F; Lalloo F; Black GC; Lim C; Moran A; Grossman AB; Hodgson SV; Freemont A; Ramsden R; Eng C; Evans DG; Maher ER Clin Endocrinol (Oxf); 2003 Dec; 59(6):728-33. PubMed ID: 14974914 [TBL] [Abstract][Full Text] [Related]
18. Mutations in SDHD are the major determinants of the clinical characteristics of Dutch head and neck paraganglioma patients. Hensen EF; Siemers MD; Jansen JC; Corssmit EP; Romijn JA; Tops CM; van der Mey AG; Devilee P; Cornelisse CJ; Bayley JP; Vriends AH Clin Endocrinol (Oxf); 2011 Nov; 75(5):650-5. PubMed ID: 21561462 [TBL] [Abstract][Full Text] [Related]
19. SDHx gene detection and clinical Phenotypic analysis of multiple paraganglioma in the head and neck. Ding Y; Feng Y; Wells M; Huang Z; Chen X Laryngoscope; 2019 Feb; 129(2):E67-E71. PubMed ID: 30484866 [TBL] [Abstract][Full Text] [Related]